Veracyte, Inc. operates as a global diagnostics company, specializing in the development and commercialization of advanced genomic tests. The company's product portfolio encompasses several key diagnostic solutions: The Afirma Genomic Sequencing Classifier and Xpression Atlas, which help patients with indeterminate thyroid nodule results avoid unnecessary surgical procedures by identifying benign cases. Decipher Prostate Biopsy and Radical Prostatectomy tests for the diagnosis of prostate cancer.